Frontline Therapy Setting
Dixie-Lee Esseltine, MD, George Mulligan, PhD
Video Categories: PMO Interview with the Innovator Series: Volume 10
Dixie-Lee Esseltine, MD and George Mulligan, PhD discuss the challenges and gaps in the current standards of care of patients with multiple myeloma, including oral and intravenous treatment options in the frontline therapy setting.
Dr. Ajai Chari talks about risk-based treatment for myeloma as the beginning of personalized medicine in the field. The 2 most recent advances are the increased use of proteasome inhibitors for those with the 4;14 translocation and treating those identified with high molecular risk more aggressively.
Dr. Boccia describes cases in which he uses CancerTYPE ID in his clinical practice.